CaƱendo, Lourdes Y.
HRN: 26-38-18 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/13/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/13/2024
12/20/2024
IVTT
600mg
Q6
Infected Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes